Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IDECABTAGENE VICLEUCEL Cause Haematotoxicity? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Haematotoxicity have been filed in association with IDECABTAGENE VICLEUCEL (Abecma). This represents 1.5% of all adverse event reports for IDECABTAGENE VICLEUCEL.

16
Reports of Haematotoxicity with IDECABTAGENE VICLEUCEL
1.5%
of all IDECABTAGENE VICLEUCEL reports
1
Deaths
1
Hospitalizations

How Dangerous Is Haematotoxicity From IDECABTAGENE VICLEUCEL?

Of the 16 reports, 1 (6.3%) resulted in death, 1 (6.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.

Is Haematotoxicity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IDECABTAGENE VICLEUCEL. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does IDECABTAGENE VICLEUCEL Cause?

Cytokine release syndrome (607) Immune effector cell-associated neurotoxicity syndrome (176) Fatigue (159) Neurotoxicity (70) Neutropenia (68) Pyrexia (67) Anaemia (63) Decreased appetite (54) Headache (54) Hypogammaglobulinaemia (54)

What Other Drugs Cause Haematotoxicity?

CYCLOPHOSPHAMIDE (1,410) DOXORUBICIN (1,180) VINCRISTINE (1,038) RITUXIMAB (812) CARBOPLATIN (803) METHOTREXATE (799) PREDNISONE (730) CYTARABINE (701) ETOPOSIDE (677) CISPLATIN (668)

Which IDECABTAGENE VICLEUCEL Alternatives Have Lower Haematotoxicity Risk?

IDECABTAGENE VICLEUCEL vs IDELALISIB IDECABTAGENE VICLEUCEL vs IDURSULFASE IDECABTAGENE VICLEUCEL vs IFOSFAMIDE IDECABTAGENE VICLEUCEL vs IGURATIMOD IDECABTAGENE VICLEUCEL vs ILOPERIDONE

Related Pages

IDECABTAGENE VICLEUCEL Full Profile All Haematotoxicity Reports All Drugs Causing Haematotoxicity IDECABTAGENE VICLEUCEL Demographics